Ventricular Arrhythmias With or Without Programmed Electrical Stimulation After Incremental Overdosage with Lidocaine, Bupivacaine, Levobupivacaine, and Ropivacaine

It is unclear whether the mechanism of death from local anesthetic (LA) intoxication is primarily a consequence of cardiac arrhythmias or myocardial contractile depression, and whether LAs might differ in this susceptibility to these two mechanisms. By using programmable electrical stimulation (PES) protocols in anesthetized, ventilated dogs, we compared the arrhythmogenic potential of bupivacaine (BUP), ropivacaine (ROP), levobupivacaine (LBUP), and lidocaine (LIDO). Open-chest dogs were randomized to receive escalating incremental infusions of the four local anesthetics until cardiovascular collapse. We assumed a concentration relationship of 4:1 for LIDO/BUP, LBUP, and ROP. The effective refractory period did not change significantly until the dose increment corresponding to target concentrations of 8 and 32 &mgr;g/mL for BUP, LBUP, ROP, and LIDO, respectively. Thirty percent to 50% increases in effective refractory period oc-curred in surviving dogs at this dose. The incidence ofspontaneous or PES-induced ventricular tachycardia and ventricular fibrillation did not differ among groups. Compared with LIDO, the incidence of PES-induced extrasystoles was more frequent for BUP- and LBUP-treated dogs (P < 0.05). ROP-treated dogs did not differ from LIDO-treated dogs with respect to PES-induced extrasystoles. At the dose increment preceding cardiovascular collapse, all LAs produced significant increases in heart rate and reductions in blood pressure compared with their respective baseline values. The incidence of programmable electrical stimulation-induced ventricular tachycardia and fibrillation with BUP does not differ from the incidence that occurs with the single S (−) enantiomers LBUP and ROP, providing further evidence against stereoselective arrhythmogenesis as a primary component of local anesthetic-induced cardiotoxicity. Implications Progressive bupivacaine intoxication in anesthetized, ventilated dogs does not produce early arrhythmogenic events. The incidence of programmable electrical stimulation-induced ventricular tachycardia and fibrillation with bupivacaine does not differ from the incidence that occurs with the single S (−) enantiomers levobupivacaine and ropivacaine, providing further evidence against stereoselective arrhythmogenesis as a primary component of local anesthetic-induced cardiotoxicity.

[1]  P. Frascarolo,et al.  A Comparison of the Electrocardiographic Cardiotoxic Effects of Racemic Bupivacaine, Levobupivacaine, and Ropivacaine in Anesthetized Swine , 2000, Anesthesia and analgesia.

[2]  Y. Hirabayashi,et al.  Dose‐related cardiovascular effects of amrinone and epinephrine in reversing bupivacaine‐induced cardiovascular depression , 1998, Acta anaesthesiologica Scandinavica.

[3]  B. Veering,et al.  Cardiovascular and Central Nervous System Effects of Intravenous Levobupivacaine and Bupivacaine in Sheep , 1998, Anesthesia and analgesia.

[4]  B. Graf,et al.  Stereospecific Effect of Bupivacaine Isomers on Atrioventricular Conduction in the Isolated Perfused Guinea Pig Heart , 1997, Anesthesiology.

[5]  J. Tamargo,et al.  Stereoselective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes. , 1995, Circulation.

[6]  J. Tamargo,et al.  Stereoselective block of a human cardiac potassium channel (Kv1.5) by bupivacaine enantiomers. , 1995, Biophysical journal.

[7]  M. Behbehani,et al.  Echocardiographic evaluation of bupivacaine cardiotoxicity. , 1994, Anesthesia and analgesia.

[8]  K. Samii,et al.  Myocardial uptake of bupivacaine: II. Pharmacokinetics and pharmacodynamics of bupivacaine enantiomers in the isolated perfused rabbit heart. , 1993, Anesthesia and analgesia.

[9]  Andrew L. Wit,et al.  The Ventricular Arrhythmias of Ischemia and Infarction: Electrophysiological Mechanisms , 1993 .

[10]  G. Strichartz,et al.  Stereoselective inhibition of neuronal sodium channels by local anesthetics. Evidence for two sites of action? , 1992, Anesthesiology.

[11]  J. Heavner,et al.  Severe hypoxia enhances central nervous system and cardiovascular toxicity of bupivacaine in lightly anesthetized pigs. , 1992, Anesthesiology.

[12]  E. Carmeliet,et al.  Stereoselective effects of the enantiomers of bupivacaine on the electrophysiological properties of the guinea‐pig papillary muscle , 1991, British journal of pharmacology.

[13]  G. Billman.  The Antiarrhythmic and Antifibrillatory Effects of Calcium Antagonists , 1991, Journal of cardiovascular pharmacology.

[14]  M. Albin,et al.  The effect of magnesium sulfate administration on cerebral and cardiac toxicity of bupivacaine in dogs. , 1990, Anesthesiology.

[15]  B. Covino,et al.  Comparative Systemic Toxicity of Convulsant and Supraconvulsant Doses of Intravenous Ropivacaine, Bupivacaine, and Lidocaine in the Conscious Dog , 1989, Anesthesia and analgesia.

[16]  W. Long,et al.  Successful resuscitation of bupivacaine-induced cardiac arrest using cardiopulmonary bypass. , 1989, Anesthesia and analgesia.

[17]  C. Bernards,et al.  Effect of midazolam and diazepam premedication on central nervous system and cardiovascular toxicity of bupivacaine in pigs. , 1989, Anesthesiology.

[18]  J. Brugada,et al.  Cardiac electrophysiological effects of bupivacaine in the anesthetized dog: relation with plasma concentration. , 1988, Archives internationales de pharmacodynamie et de therapie.

[19]  D. M. Wheeler,et al.  The electrophysiologic actions of lidocaine and bupivacaine in the isolated, perfused canine heart. , 1988, Anesthesiology.

[20]  G. Kasten,et al.  Comparison of Resuscitation of Sheep and Dogs after Bupivacaine‐Induced Cardiovascular Collapse , 1986, Anesthesia and analgesia.

[21]  G. Kasten.  Amide Local Anesthetic Alterations of Effective Refractory Period Temporal Dispersion: Relationship to Ventricular Arrhythmias , 1986, Anesthesiology.

[22]  M. Rosen,et al.  Bupivacaine-induced cardiotoxicity in hypoxic and acidotic sheep. , 1985 .

[23]  H. Refsum,et al.  Cardiac electrophysiologic and hemodynamic effects related to plasma levels of bupivacaine in the dog. , 1985, Anesthesia and analgesia.

[24]  L. Hondeghem,et al.  Mechanism for Bupivacaine Depression of Cardiac Conduction: Fast Block of Sodium Channels during the Action Potential with Slow Recovery from Block during Diastole , 1985, Anesthesiology.

[25]  M. Rosen,et al.  Bupivacaine‐induced Cardiac Arrhythmias in Sheep , 1984, Anesthesiology.

[26]  B. Covino,et al.  Comparative CNS Toxicity of Lidocaine, Etidocaine, Bupivacaine, and Tetracaine in Awake Dogs Following Rapid Intravenous Administration , 1983, Anesthesia and analgesia.

[27]  E. Moore,et al.  Initiation of ventricular tachyarrhythmia with programmed stimulation: sensitivity and specificity in an experimental canine model. , 1982, Surgery.

[28]  B. Covino,et al.  Acute Cardiovascular Toxicity of Intravenous Amide Local Anesthetics in Anesthetized Ventilated Dogs , 1982, Anesthesia and analgesia.

[29]  A. K. Dawson,et al.  Effect of pentobarbital anesthesia on vulnerability to ventricular fibrillation. , 1980, The American journal of physiology.

[30]  R. H. de Jong,et al.  Deaths from Local Anesthetic‐Induced Convulsions in Mice , 1980, Anesthesia and analgesia.

[31]  G A Albright,et al.  Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. , 1979, Anesthesiology.

[32]  R. Lazzara,et al.  Electrocardiographic antecedents of primary ventricular fibrillation. Value of the R-on-T phenomenon in myocardial infarction. , 1976, British heart journal.

[33]  M. Laubie,et al.  Localization of the central sympatho-inhibitory effect of a narcotic analgesic agent, fentanyl, in cats. , 1975, European journal of pharmacology.

[34]  J. Spear,et al.  Ventricular fibrillation threshold; its physiological and pharmacological importance. , 1975, Archives of internal medicine.

[35]  D. Scott.  Evaluation of the toxicity of local anaesthetic agents in man. , 1975, British journal of anaesthesia.